Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-16

Clinical Trial Update: Allopurinol in Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating allopurinol in patients with acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED